Financial Statements · Financial Reporting

Narafarm OÜ

Official identifier 12139312Record date 31 Dec 2025
Estonia

Report

Legal form
OÜ
Report status
Registered

Dates

Reporting year
2025
Period start
1 Jan 2025
Submitted date
29 Jun 2026

Report

Consolidated
No
Audited
No

Financial metrics

StatementMetricValue
Bilanss, detailneAssets579,168
Bilanss, detailneCash and cash equivalents106,311
Bilanss, detailneCurrent assets219,785
Bilanss, detailneCurrent liabilities81,368
Bilanss, detailneEquity388,233
Bilanss, detailneShare capital at nominal value2,500
Bilanss, detailneNon-current assets359,383
Bilanss, detailneNon-current liabilities109,567
Bilanss, detailneRetained earnings (loss) from previous periods401,398
Kahjumi katmise ettepanekRetained earnings (loss) from previous periods401,398
Income statement scheme 1Depreciation and impairment of non-current assets-93,376
Income statement scheme 1Labour costs-12,528
Income statement scheme 1Revenue108,085
Income statement scheme 1Annual period profit / loss-15,915
Income statement scheme 1Operating profit (loss)-2,779
Income statement scheme 1Profit (loss) before income tax-15,915
Note: Labour costsEmployees1
Note: Labour costsLabour costs12,528

Linked company

Company: Narafarm OÜ

Source

Estonian e-Business Register Annual Reports open data

View published source

Back to Financial Statements